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Abstract. To define the actin-binding site within the
N11 2-terminal domain (residues 1-245) of chick smooth
muscle a-actinin, we expressed a series of a-actinin
deletion mutants in monkey Cos cells . Mutant a-actin-
ins in which residues 2-19, 217-242, and 196-242
were deleted still retained the ability to target to actin
filaments and filament ends, suggesting that the actin-
binding site is located within residues 20-195. When
a truncated a-actinin (residues 1-290) was expressed
in Cos cells, the protein localized exclusively to fila-
ment ends . This activity was retained by a deletion
mutant lacking residues 196-242, confirming that
these are not essential for actin binding . The actin-
binding site in a-actinin was further defined by express-
ing both wild-type and mutant actin-binding domains
as fusion proteins in E. coli . Analysis of the ability of
a-ACTININ is a rod-shaped F-actin cross-linking protein
found in both muscle and nonmuscle cells at sites where ac-
tin is attached to a variety of intracellular structures. It is a
homodimer with subunits of molecular mass 94-103 kD ar-
ranged in an antiparallel orientation . Smooth, skeletal, and
nonmuscle isoforms of the protein have been identified, the
only clear functional difference being that binding of the
nonmuscle isoform to actin is inhibited by calcium, whereas
the muscle isoforms are calcium insensitive in this respect
(reviewed in Blanchard et al ., 1989) . Analysis of the de-
duced sequence of the chick smooth muscle isoform of the
protein shows that a-actinin can be divided into three distinct
domains, an NH2-terminal actin-binding domain spanning
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Since this work was submitted for publication, Bresnick et al . (Bresnick,
A . R., P. A . Janmey, and J . Condeelis . 1991 . J. Mol. Chem. 268 :12989-
12993) have shown thatantibodies to the27 amino acids implicated in bind-
ing ofABP120 to actin can immune precipitate ABP120 from cell lysates,
suggesting that these residues are on the surface of the protein as expected
for an actin-binding site. Fab' fragments ofthe antibody inhibited ABP120
binding to actin, and the synthetic 27 mer inhibited actin cross-linking by
ABP120. Evidence wasalso presented that the synthetic 27mercosediments
with actin .
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such proteins to bind to F-actin in vitro showed that
the binding site was located between residues 108 and
189 . Using both in vivo and in vitro assays, we have
also shown that the sequence KTFT, which is conserved
in several members of the a-actinin family of actin-
binding proteins (residues 36-39 in the chick smooth
muscle protein) is not essential for actin binding . Fi-
nally, we have established that the NH2-terminal do-
main of dystrophin is functionally as well as structurally
homologous to that in a-actinin . Thus, a chimeric
protein containing the N112-terminal region of dystro-
phin (residues 1-233) fused to a-actinin residues 244-
888 localized to actin-containing structures when ex-
pressed in Cos cells . Furthermore, an E . coli-expressed
fusion protein containing dystrophin residues 1-233
was able to bind to F-actin in vitro .
approximately the first 245 amino acid residues, four spec-
trin-like repeats (residues 246-713), and a COOH-terminal
region (residues 714-888) containing two EF-hand calcium
binding motifs (Baron et al ., 1987) . Sequence comparisons
show that the actin-binding domain of a-actinin is homolo-
gous with that found in a number of other actin-binding pro-
teins including ß-spectrin (Karinch et al ., 1990), fimbrin
(de Arruda et al ., 1990), filamin (Gorlin et al., 1990), and
the Dictyostelium discoideum 120-kD actin gelation factor
called ABP120 (Noegel et al., 1989) . The N112-terminal
region of dystrophin also shows sequence similarity to the
actin-binding domains found in this family of proteins, sug-
gesting that dystrophin is also likely to be an actin-binding
protein (Hammonds, 1987 ; Davison and Critchley, 1988) .
However, at present there is no direct evidence that dystro-
phin can bind actin .
The actin-binding domain of a-actinin can be liberated
from the whole molecule as a 27-kD polypeptide by ther-
molysin digestion, and this polypeptide retains the ability to
bind to F-actin (Mimura and Asano, 1986) . However, little
is known about those sequences within this domain which
are essential for actin binding . Studies on the actin-binding
domains of other members of this family of actin-binding
proteins have begun to provide some information in this re-
1369gard. Thus, a human (3-spectrin tryptic fragment (16.5 kD)
spanning residues 47 throughto approximately 186 hasbeen
shown to possess F-actin-binding activity (Karinch et al .,
1990). Similarly, tryptic digestionof ABP-120yields a 17-kD
polypeptide which is reported to bind F-actin, whereas a
14-kD tryptic fragment derived from this polypeptide by
loss of a further 27 NH2-terminal residues wasunable to do
so. These 27 amino acids span residues 89-115 in the se-
quence of ABP-120 (Bresnick et al., 1990). Levine et al.
(1990) have also reported that a synthetic peptide based on
dystrophin residues 10-32 was able to interact with F-actin
as judged by nuclear magnetic resonance. This region con-
tains thesequence KTFT which is found in the actin-binding
domain of several of this family of actin-binding proteins.
We have previously shown that when a cDNA encoding
the chick smooth muscle isoform of a-actinin wasexpressed
in monkey Cos cells, the expressed proteintargeted to actin
microfilaments and to filament ends where they terminate at
cell-matrix junctions (Jackson et al., 1989). This distribu-
tion mirrorsthat ofthe endogenous a-actinin, andis thought
to reflect the ability of the protein to bind to F-actin. In this
study we have used mutagenesis in conjunction with this as-
say to further define the actin-binding site within a-actinin.
We have also expressedtheactin-binding domain ofa-actinin
in Fscherichia coli as afusion proteinwith glutathione-s-trans-
ferase (GST)I and have monitored the effects of deletions
and point mutations on the ability of the fusion protein to
bind to F-actinin vitro. Theresultsofthese studiesshow that
theactin-bindingsite in a-actininis locatedbetween residues
108 and 189. Finally, we have tested thehypothesis that dys-
trophin contains a functional actin-binding site. Thus, we
have replaced theactin-binding domain of a-actininwith the
equivalent domain from dystrophin andinvestigated theabil-
ityoftheexpressedproteinto targetto actin-containing struc-
tures in Cos cells. The NH2-terminal domain of dystrophin
has also been expressed as a fusion protein in E. coli and
its ability to bind to F-actin assayed in vitro. The results
clearly demonstrate that dystrophin contains a functional
actin-binding site.
Materials and Methods
Plasmid Constructs Used in Transient
Expression Experiments
A full-length chicksmooth muscle «-actinin cDNA (clone C17) (Baron et
al., 1987) was isolated as an EcoRI restriction enzyme fragment from a
Bluescript construct. The ends were filled in andthe fragment blunt-end
ligated into the Smal site of the eukaryotic plasmid expression vector
pSVL40, which contains the SV40 late promoter, poly(A) addition se-
quence and poly(A) tract(Pharmacia Fine Chemicals, Uppsala, Sweden).
This construct is referred to as pSVL/C17 (Fig. 1). Deletion ofthenucleo-
tidesencoding residues 1-218 was achieved by purifyinga3' EcoRVEcoRI
restriction enzyme fragment from C17 (Fig. 1), followed by blunt-endliga-
tion into theSmaI site of pSVL40. Translation from this construct depends
on initiation at methionine 222. This mutant is referred to as pSVL/N222
(Fig. 1). Theauthentic initiating methionine codonis retained in all remain-
ingconstructs. Otherdeletionmutants as well aspointmutationsweremade
by site-directed mutagenesis usingC17subclonedintotheEcoRlsite ofthe
M13-based vector, mICE mp18 (Eperon, 1986). The frequency ofisolation
of mutants wasincreasedby preparing single-stranded template in the dut-
ungstrain ofE. coli (Kunkel et al ., 1987). Screening formutants wascar-
1. Abbreviations used in this paper: GST, glutathione-s-transferase; PCR,
polymerase chain reaction.
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Figure 1. a-Actinin and dystrophin cDNA constructs. C17 is a
3.6-kb cDNA encoding the complete 888residues ofchicksmooth
muscle a-actinin(Baron et al., 1987). Theapproximate position of
useful restriction enzyme sites as well as the domain structure of
the protein are shown. The actin-bindingdomain (ABD) of «-acti-
ninspanning residues 1-245 (numbering includes initiating methio-
nine) is indicatedby shading. The four spectrin-like repeats found
in a-actinin (residues 246-713) arenumbered,andtheapproximate
position of the two EF-hand calcium binding motifs (E-F) is also
shown. The following a-actinin constructs were made in the eu-
karyotic expression vector pSVL40 (A): pSVL/C17 encodes full-
length chick a-actinin; pSVL/N222, deletion of residues 1-221;
pSVL/N20, deletion of residues 2-19; pSVL/N47, deletion of resi-
dues 2-46; pSVL/C216, deletion of residues 217-242; pSVL/C195,
deletion of residues 196-242. The pSVL/ABD construct was de-
rived from pSVL/C17 and encodes the actin-binding domain of
a-actinin extendingup to residue 290; pSVL/ABD195 was derived
from pSVL/C195; pSVL/DaA encodes residues 1-233 of human
dystrophin (shown in black) fused to residues 244-888 of chick
a-actinin. Theauthentic AUG translation start codon wasretained
in all pSVL40 constructs except for pSVL/N222, which relies on
initiation at an internal AUG encoding methionine 222. a-Actinin
anddystrophin cDNAs were also expressedas GST fusion proteins
using the prokaryotic vector pGEX-2 (B). The constructs were:
pGEX/aA, encodesa-actininresidues 1-269;pGEX/N108, encodes
a-actinin residues 108-242; pGEX/C189, encodes a-actinin resi-
dues 1-189; and pGEX/Dys, encodes dystrophin residues 1-233.
ried outby T-track sequencing using thedideoxy chaintermination method
of Sanger et al. (1977) . All mutants were sequenced across the region of
interest before subcloning into pSVLA0.
A 5' EcoRI-BamHl restriction enzyme fragment of C17 which encodes
the NH2-terminal actin-binding domain of a-actinin (approximately
residues 1-245) andterminates at residue290(Fig. 1) wasblunt-endligated
into the Snua site of pSVL40 (pSVL/ABD) . A similar construct (Fig. 1)
in which the nucleotides encoding residues 196-242 had been deleted by
mutagenesis wasgenerated from a mutant designated pSVL/C195by exci-
sion of a 1.8-kb 3' BamHI fragment (BamHI cuts once in C17 and once in
thepSVL40 polylinker3'to theSmaI site). Thecutplasmid wasgel-purified
and religated (pSVL/ABD195).
A pSVL40 constructencoding NH2-terminal residues 1-233 of human
dystrophin fused to residues 244-888 of chicksmooth muscle a-actinin,
andtermed pSVL/DaA (Fig. 1), wasgeneratedas follows. An Xbal site wasintroduced into the a-actinin clone C17 (using site-directed mutagenesis)
at the junction between residues 244 and 245. This was achieved by a single
base change which resulted in the substitution of an arginine for serine at
residue 245. This construct was excised from the mICE vector as an EcoRI
fragment, and blunt-end ligated into the Smal site of pSVL40. Nucleotides
encoding residues 1-243 were excised from the recombinant plasmid using
a 5' XhoI site within the pSVL40 polylinker and the newly introduced XbaI
site within C17. This fragment was replaced by a polymerise chain reaction
(PCR) fragment (with compatible restriction sites) encoding residues 1-233
of human dystrophin. The human dystrophin plasmid construct pCF27
(Koenig et al ., 1987) (kindly donated by Dr. D. Love, John Radcliffe Hospi-
tal, Oxford, UK) was used as template for the PCR reaction. pCF27 con-
sisted of pUC13 containing a 2.2-kb cDNA insert corresponding to the
5' end of the human dystrophin molecule. The pSVL/DctA construct was
authenticated both by restriction mapping and DNA sequencing.
TransientExpressionofpSVL40Plasmid Constructs
in Monkey Cos Cells
Plasmid DNA for transfection was prepared using the alkaline lysis method
followed by purification using polyethylene glycol precipitation as de-
scribed by Sambrook et al. (1989). The sequence of all constructs was
confirmed by double-stranded sequencing (Mierendorf and Pfeffer, 1987)
of plasmid DNA prepared for transfection. Transfection of plasmid DNA
into Cos cells was carried out using the DEAE-dextrin method (Cullen,
1987) as previously described (Jackson et al., 1989) using 50 P.g of DNA
per 100-mm dish. For immunofluorescence localization of the expressed
a-actinin, cells (40 h after transfection) were permeabilized with 0.5%
(vol/vol) Triton X-100 in 50 mM MES buffer, pH 6.0, 3 mM EGTA, and
5 MM MgCl2 for 2 min and fixed with 3.7% (wt/vol) formaldehyde in PBS
(15 min). The expressed chick a-actinin was detected exactly as described
previously (Jackson et al., 1989) using a rabbit antibody against chicken
gizzard a-actinin which had been preadsorbed against permeabilized mon-
key Cos cells. The antibody, which is specific for chick a-actinin (Jackson
et al., 1989) has been shown to recognize epitopes within the actin-binding
domain and spectrin-like repeats of a-actinin (data not shown). For im-
munofluorescence, bound antibody was detected using a Texas red-labeled
anti-rabbitantibody (Amersham International, Amersham, UK). Both anti-
bodies were diluted 1:50 inPBS before use. Cells were costained for F-actin
using NBD-phallacidin (Molecular Probes, Inc., Eugene, OR). Metabolic
labeling of cell cultures with [35S]methionine, immune precipitation, and
detection oflabeled proteins were carried out as described previously (Jack-
son et al., 1989).
Expression oftheActin-bindingDomainsofaActinin
andDystrophin as GSTFusion Proteins in E. coli
An Ncol-HincII DNA restriction fragment derived from the smooth muscle
a-actinin cDNA C17 and encoding the actin-binding domain together with
an additional 27 COOH-terminal aminoacids (residues 1-269) was initially
subcloned into the NcoI/StuI sites of the pET3 expression vector (a con-
struct kindly donated by Dr M. Wey, Medical Research Council Molecular
Biology Laboratories, Cambridge, UK). This fragment was excised from
pET3 using flanking BamHI andEcoRI restriction sites and cloned in frame
into the GST gene contained in the prokaryotic plasmid expression vector
pGEX-2 (Pharmacia Fine Chemicals). The resulting construct was desig-
nated pGEX/aA (Fig. 1). A construct encoding residues 108-242 of chick
smooth muscle a-actinin fused in frame to GST (pGEX/N10ß) (Fig. 1) was
generated by PCR using the cDNA clone C17 as template. The 5' oligonu-
cleotide primer contained a BamHI site and the 3' primer an EcoRI site,
enabling the PCR product to be force-cloned into BamHI/EcoRI cut pGEX-
2. A construct encoding residues 1-189 ofchick smooth muscle a-actinin
fusedto GST (pGEX/C189) (Fig. 1) was madeby cutting the pGEX/aA con-
struct at a convenient Sacl site within the actin-binding domain and at the
EcoRI site within the pGEX-2 polylinker. After removal ofthe SacI-EcoRI
fragment, the vector was relegated after the ends were filled in using T4
DNA polymerase 1. Constructs encoding residues 2-242 of a-actinin, but
in which the KTFT sequence had been mutated, were generated by PCR
using 5'and 3'primers containing BamHI and EcoRI sites, respectively, and
the pSVL/KTFT mutant constructs as templates. PCRproducts were force-
cloned into BamHI/EcoRI cut pGEX-2. A DNA fragment encoding resi-
dues 1-233 of human dystrophin was synthesized by PCR and cloned in
frame into the Smal site of pGEX-2 (pGEX/Dys) (Fig. 1). The validity of
all constructs was established by restriction enzyme analysis and double-
strand sequencing. The GST fusion proteins were expressed in E. coli
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and purified from cell lysates exactly as described by Smith and Johnson
(1988) using a glutathione-agarose affinity matrix (Sigma Chemical Co.,
St. Louis, MO).
Actin CosedimentationAssay
The ability ofthe GST fusion proteins to bind actin was investigated using
an actin cosedimentation assay. 5 pl of rabbit muscle G-actin (5 UgIAI;
Sigma Chemical Co.) and the appropriate fusion protein were mixed in a
total volume of 100 pl of buffer (10 mM Tris-HCl, pH 8.0, 0.2 mM ATP,
0.2 mM dithiothreitol, 1 mM NaN3, 0.2 mM CaC12). The fusion proteins
under analysis were relatively insoluble in this buffer and Triton X-100
(0.1% vol/vol) was therefore added to reduce sedimentation of the fusion
proteins in the absence of actin. Actin polymerization was initiated by the
addition of 3 mM MgC12 and 100 mM NaCl, and the samples were in-
cubated for 1 h at room temperature. Samples were centrifuged with or
without actin in an airfuge (Beckman Instruments, Inc., Fullerton, CA) at
85,000 rpm (100,000 g) for 30 min. The entire supernatant and pellet were
analyzed by SDS-PAGE (12% acrylamide). Where the size of the fusion
protein tested differed substantially from that of actin, gels were simply
stained with Coomassie blue. Unfortunately, fusion proteins encoded by
pGEX/N10ß and pGEX/C1ß9 (41 and 48 kD, respectively) were difficult
to resolve from the actin (43 kD). To overcome this problem, proteins
resolved by SDS-PAGE were transferred to nitrocellulose and the a-actinin
fusion proteins detected with antibodies to ct-actinin. The pGEX/N10ß fu-
sion protein(a-actinin residues 108-242) was detected using the polyclonal
rabbitanti-chicken gizzard a-actininantibody. The pGEX/Cl 89 fusion pro-
tein (a-actinin residues 1-189) was not detected using this antiserum, and
a monoclonal antibody to human platelet a-actinin (a generous gift from
Dr. J. M. Wilkinson, Royal College of Surgeons, London, UK) was used
in this case. Bound antibodies were revealed using 1:10,000 dilutions of al-
kaline phosphatase-conjugated anti-rabbit and anti-mouse IgG's (Promega
Corp., Madison, WI), respectively.
Results
Expression ofChick aActininin Monkey Cos Cells
A cDNA (C17) encoding the complete sequence of chick
smooth muscle a-actinin (Baron et al., 1987) was subcloned
into the eukaryotic expression vector pSVL40 (pSVL/Cl7).
The chick «-actinin was transiently expressed in monkey
Cos cells and the intracellular distribution of the expressed
protein was detected by immunofluorescence using an anti-
body rendered specific for chick a-actinin . The expressed
protein was distributed along actin microfilaments, and was
also localized to filament ends where they terminate at cell-
matrix junctions (adhesion plaques) (Fig. 2, A and B).
To establish thattargetingofchick a-actinin to these struc-
tures was entirely due to the actin-binding domain ofthe pro-
tein, a plasmid construct (pSVL/N222) was made in which
the nucleotides encoding NH2-terminal residues 1-218
were deleted by excisionof a 5' EcoRI-EcoRV restriction en-
zyme fragment (Fig. 1). Expression of the truncated protein
(molecular mass 70 kD), which is dependent on translation
initiating at methionine residue 222, was confirmed by im-
mune precipitation using lysates from transfected Cos cells
grown in the presence of [338]methionine (data not shown).
Immunofluorescence studies showed that the mutant a-actinin
was unable to localize to either actin filaments or adhesion
plaques, although the integrity of these structures was con-
firmed by counterstaining for actin using NBD-phallicidin
(Fig. 2, Cand D).
TheEffect ofDeletions within theActin-binding
DomainofaActinin ontheIntracellular Localization
oftheExpressedProtein
The fact that targeting ofa-actinin to actin-containing struc-
1371Figure 2 . Expression of a-actinin and
dystrophincDNA constructs in Cos cells .
Plasmid constructs expressed werepSVL/
C17(A,B), pSVL/N222(CD),andpSVL/
DceA (E-H) . Transfected cells were stained
for the expressed chick a-actinins as de-
scribed in Materials and Methods using
a rabbit antibody to chick a-actinin(ACE,
G,H) . Double-staining for actin was
achieved using NBD-phallacidin(BD F) .
Large arrowheads indicate the location of
adhesion plaques and small arrowheads the
location of actin filaments . Magnification
bar, 5 jim .tures within the cell is dependent on the NHz-terminal do-
main of the protein provides a system with which to further
define the actin-binding site within this domain . We there-
fore constructed a number of a-actinin mutants in which
nucleotide sequences encoding both NHz- and 000H-
terminal portions of the actin-binding domain were deleted .
These mutants were subcloned intopSVL40 and transiently
expressed in Cos cells . Deletion of NHz-terminal residues
2-19 (pSVL/N20) did not affect the ability of the expressed
a-actinin to localize to actin filaments or adhesion plaques
(Fig . 3 A) . In contrast, deletion of NHz-terminal residues
2-46 (pSVL/N47) resulted in expression of a protein that
was found in aggregates within the cytoplasm (Fig . 3 B) . The
result suggests that this deletion has led to synthesis of an in-
soluble protein, making it impossible to draw any conclu-
sions from this particular mutant .
The expression and intracellular distribution of a deletion
mutant lacking residues 217-242 at the COOH-terminal end
of the actin-binding domain of a-actinin (pSVL/C216) is
shown in Fig . 3 C. The expressed protein retained the ability
to localize to adhesion plaques and actin stress fibers. An
a-actinin molecule lacking residues 196-242 (pSVL/C195)
was also able to localize to actin-containing structures (Fig .
3 D), but this deletion produced a marked alteration in the
properties of the expressed protein, much of which was
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Figure 3. Expression of a-ac-
tinin mutants containing dele-
tions within the actin-binding
domain in Cos cells . ThepSV
L40 constructs expressed were :
N20 (A), N47 (B), C216 (C),
and C195 (D) . Transfeçted
cells were stained for a-actinin
as described in Materials and
Methodsusing a rabbitantibody
tochicka-actinin . Large arrow-
heads indicate the location of
adhesion plaques (A, C) and
insoluble aggregates (B, D) .
Small arrowheads indicate the
location ofactin filaments . Mag-
nification bar, 5 )Am .
found in aggregates deposited throughout the cytoplasm .
These results therefore suggest that the actin-binding site in
a-actinin is contained within residues 20-195.
Expression ofTruncated aActinins Containing the
Actin-binding Domain in CosCells
In an attempt to overcome the solubility problems associated
with expression of full-length a-actinins containing dele-
tions within the actin-binding domain, we expressed trun-
cated derivatives of these mutants spanning residues 1-290.
Interestingly, the expressed wild-type protein encoded by the
plasmid construct pSVL/ABD appeared to localize largely
to the ends of actin filaments, and little was found distributed
along the actin filaments themselves (Fig . 4, A and B) . A
mutant lacking residues 196-242 (pSVL/ABD195) also re-
tained the ability to localize to filament ends (Fig . 4, C and
D), consistent with our previous conclusion that these
residues are not required for actin binding . However, much
ofthe expressed protein remained diffusely distributed in the
cytoplasm even though the cells had been permeabilized
with detergent. a-Actinins that remain in the soluble pool are
normally extracted under these conditions (Fig. 2 C), sug-
gesting that the truncated mutant a-actinin(pSVL/ABD195)
is only marginally more soluble than the full-length mutant
(pSVL/C195) .
1373Expression oftheActin-bindingDomain of
aActinin asaFusion Protein in E. coliandAnalysis
ofActin BindingIn Intro
The insolubility of a-actinin deletion mutants expressed in
Cos cells precluded the use of this system to further define
the actin-binding site in a-actinin . We therefore sought to ex-
press the actin-binding domain of a-actinin in E. coli . The
expressed protein (residues 1-269) was soluble and was able
to bind F-actin (data not shown) . Unfortunately, all deletion
mutants tested were insoluble, and we were unable to solu-
bilize them from inclusionbodies using standard procedures .
However, when deletion mutants were expressed as fusion
proteins with GST using thepGEX expression system (Smith
and Johnson, 1988), the proteins remained sufficiently solu-
ble fo'r purification and use in actin-binding studies. The
ability of a fusion protein containing a-actinin residues
1-269 to cosediment with F-actin as revealed by SDS-PAGE
and Coomassie blue staining ofthe gel is shown in Fig . 5 b .
The fusion protein was found in the pellet (p) after centrifu-
gation in the presence (+) of F-actin, but remained in the su-
pernatant (s) when centrifuged in the absence (-) of actin .
GST alone did not bind to F-actin (Fig . 5 a) . The mutant
fusion proteins tested were pGEX/Nl08, which contains
a-actinin residues 108-242, and pGEX/C189, which con-
tains a-actinin residues 1-189. Unfortunately, both fusion
proteins have molecular weights similar to that ofactin, and
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Figure 4. Expression of trun-
cated a-actinins containing the
actin-binding . domain in Cos
cells . The pSVL40 constructs
expressedwere :pSVL/ABD (A,
B) and pSVL/ABD195 (C, D) .
Transfected cells were stained
for a-actinin as described in
Materials and Methods using
a rabbit antibody to chick
a-actinin (A, C) . Double-stain-
ing for actin was achieved using
NBD-phallacidin (B, D) . Large
arrowheads indicate the loca-
tion of adhesion plaques and
small arrowheads indicate the
location of actin stress fibers .
Magnification bar, 3 pm .
the proteins were therefore detected by Western blotting in-
stead of staining with Coomassie blue . Interestingly, both
pGEX/Nl08 (Fig . 6 a) and pGEX/C189 (Fig . 6 b) retained
the ability to bind F-actin . A fusion protein containing
residues 1-107 did not bind F-actin (data not shown) . This
result suggests that a-actinin residues 108-189 contain an
actin-binding site .
Expression ofaActinin KTFT Mutants in Cos Cells
The amino acid sequence KTFT in dystrophin (residues 19-
22) has been implicated in binding to F-actin (Levine et
al ., 1990) . This sequence is totally conserved among all
a-actinins sequenced to date (residues 36-39 inchick smooth
muscle a-actinin) . To analyzethe importanceofthis sequence
in the binding of a-actinin to actin, we have expressed a num-
ber of a-actinin mutants affecting this region of the protein
in Cos cells. Initially, we expressed an a-actinin construct
in which nucleotides encoding these residues had been de-
leted . However, the expressed protein accumulated in aggre-
gates, suggesting that it was insoluble (Fig . 7 A) . Interestingly,
cells expressing this construct were devoid of actin filaments
(Fig . 7 B) . We therefore wenton to express mutants contain-
ing both conservative and nonconservative substitutions of
the KTFT sequence . Despite the fact that this sequence is
totally conserved in all a-actinins, substitution of the se-
quence with amino acids of similar physico-chemical prop-
1374Figure 5 . Binding of fusion proteins containing the NH2-terminal
domains ofa-actinin and dystrophin to F-actin . GST or GST fusion
proteins containing residues 1-269 of a-actinin (pGEX/aA) or
residues 1-233 of dystrophin (pGEX/Dys) were expressed in and
purified fromE. coli, and their ability to bind F-actin was assayed
using a cosedimentation assay. Proteins were incubated with (+)
or without (-) actin before centrifugation, and the supernatants (s)
and pellets (p) were analyzed by SDS-PAGE followed by staining
with Coomassie blue . GST alone (a) ; GST fusion proteins contain-
ing the NH2-terminal domains of a-actinin (aA) (b), and dystro-
phin (Dys) (c). The position of actin (A) and the fusion proteins is
indicated (arrows) .
erties (RSYS) had no effect on the ability of the expressed
a-actinin to localize to actin filaments and adhesion plaques
(Fig . 7, C andD) . Perhaps more surprising was the observa-
tion that the lysine residue plus a flanking arginine residue
could be replaced by glutamate residues (EETFT) without
any apparent effect on targeting of the expressedprotein (Fig .
7 E) . Three further mutations were made where residues 37,
38, and 39 (TFT) were each in turn substituted with alanine
residues . Again, all three a-actinin mutants retained the
ability to target to actin filaments and adhesion plaques (Fig .
7, F-H) .
TheEffect ofMutations in theKTFTSequence on
ActinBindingIn Vitro
The actin-binding domains of the above KTFT mutants
(residues 2-242) were also expressed asGST fusionproteins
inE . coli, and their ability to bind to F-actin was analyzed
in vitro . Sufficient soluble protein was obtained with all mu-
tants, including the KTFT deletion mutant, although the
majority of the expressed proteins proved to be insoluble
(data not shown) . All mutant fusion proteins were less stable
than the wild-type protein, and the purified proteins had to
be used immediately after purification . Nevertheless, the
results clearly demonstrate that all intact fusion proteins (but
not their degradation products) were capable of binding to
F-actin, including theKTFT deletion mutant (Fig . 8) . These
results are consistent with those obtained from transfection
experiments, and suggest that the KTFT motif is not essen-
tial for actin binding . Nevertheless, the amount of fusion
protein bound to F-actin varied with the different mutations .
In an attempt to quantify the relative binding activities of the
different mutants, the amounts of each fusion protein bound
to actin was measured by densitometry (Table I) . Approxi-
mately 92% of the wild-type fusion protein sedimented in
the presence (but not in the absence) of F-actin (Fig . 5 6 and
Table I) . All mutants showed a substantial reduction in bind-
ing activity compared with the wild-type protein, although
the differences in activities between the various mutants were
surprisingly small .
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Figure 6 . Binding of fusion proteins containing actin-binding do-
main deletion mutants to F-actin . Fusion proteins encoded by
pGEX/Nl08 (residues 108-242 ; a) and pGEX/Cl89 (residues
1-189 ; b) were incubated with (+) or without (-) actin before cen-
trifugation . The supernatants (s) and pellets (p) were analyzed by
SDS-PAGE before detection ofthe fusion proteins by immunoblot-
ting as described in Materials and Methods . The positions of the
fusion proteins (FP) and actin (A) are indicated by arrows .
Expression ofa DystrophinlaActinin Chimeric
Proteinin Cos Cells
The observation that the NH2-terminal region of dystrophin
shows sequence similarity to the actin-binding domain of
a-actinin (Hammonds, 1987 ; Davison and Critchley, 1988)
has led to speculation that dystrophin is also an actin-binding
protein . To test this prediction, we constructed a chimeric
cDNA encoding residues 1-233 ofhuman dystrophin fused
in frame to chick a-actinin residues 244-888. Tb facilitate
the construction, the codon encoding serine residue 245 in
the a-actinin sequence was mutated to an arginine codon .
This substitution had no effect on the intracellular localiza-
tion of the expressed a-actinin molecule (data not shown) .
When the construct encoding the dystrophin/cY-actinin chi-
mera (pSVL/DoA) was expressed in Cos cells, the fusion
protein could clearly be seen to target to actin filaments and
adhesion plaques (Fig . 2, E-H) . This result shows that the
NH2-terminal domain of dystrophin is functionally homolo-
gous to that of a-actinin, and suggests that dystrophin is in-
deed an actin-binding protein .
Expression of theNHZ-terminal Domain of
Dystrophin asa Fusion Protein inE. coli:Analysis of
ItsActin-binding Properties In Vitro
When dystrophin residues 1-233 were expressed inE . coli,
theprotein was found in inclusion bodies from which it could
not be solubilized . However, when these same residues were
expressed as a GST fusion protein, sufficient protein re-
mained in a soluble form to allow purification of the fusion
protein . However, the fusion protein was somewhat unstable
and had to be used in actin cosedimentation assays immedi-
ately after purification . The results of such experiments are
shown in Fig . 5 c . The dystrophin fusion protein was almost
exclusively recovered in the pellet fraction (p) when cen-
trifuged in the presence (+) of F-actin, although it remained
in the supernatant (s) fraction when centrifuged in the ab-
sence (-) of actin . It is therefore clear that the NH2-
terminal domain of dystrophin contains a functional actin-
binding site .
Discussion
a-Actinin is one of a growing family of actin-binding pro-
1375Figure 7 . Expression of chick a-actinin
KTFT mutants in Cos cells . pSVL/
a-actinin cDNA constructs containing
mutations in the R/K KTFT sequence
(residues 35-39) were transiently ex-
pressed in Cos cells, and the expressed
proteins were detected by immunofluo-
rescence using a rabbit antibody to chick
a-actinin (A, C, E-H) . Double-staining
for actin was achieved using NBD-phal-
lacidin (B, D) . Deletion of theKTFT se-
quence (A, B) . Substitutions were as fol-
lows : RSYS (C, D), EETFT (E), KAFT
(F), KTAT (G), and KTFA (H) . Large
arrowheads indicate the location of adhe-
sion plaques (C-H) and insoluble aggre-
gates (A, B) . Small arrowheads indicate
the location of actin filaments (C-H) .
Magnification bar, 5 pm .Figure 8 . Binding of fusion proteins containing the actin-binding
domain ofa-actinin to F-actin.The effect ofmutations in theKTFT
sequence. Fusion proteins (a-actinin residues 2-242) were incu-
bated with (+) or without (-) actin before centrifugation, and the
supernatants (s) and pellets (p) were analyzed by SDS-PAGE and
Coomassieblue staining. Thepositionsof the fusion proteins (FP)
and actin (A) are indicated by arrows. KTFT deletion mutant (a).
Substitution mutants were as follows : RSYS (b), EETFT (c),
KAFT (d), KTAT (e), and KTFA (f).
teins that have homologous N142-terminal actin-binding do-
mains (Matsudaira, 1991) . Inspection of the aligned actin-
binding domain sequences provides little information about
the likely location oftheactin-binding site within thedomain
(Fig . 9) . There are 11 positions where sequence identity is
maintained, 8 of whicharehydrophobic aminoacids . There
are many other positions where the physico-chemical prop-
erty of the residue is conserved. In an attempt to further
define theactin-binding site in a-actinin, we havemade a se-
ries of NH2- and COON-terminal deletions within the
actin-binding domain, and have analyzed theeffects of these
deletions on actin binding in vivo and in vitro . Deletion of
N112-terminal residues 2-19 of a-actinin had no apparent
effect on the ability of a-actinin to target to actin filaments
and filament ends when expressed in Cos cells . Deletion of
TableL TheBinding ofa-ActininActin-bindingDomain
KTFTMutantGSTFusion Proteins to F-Actin
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Figure 9 . Amino acid sequence alignments of the actin-bindingdo-
mainsofthe a-actinin family proteins . a-Actinin (AaC), dystrophin
(DyC), 0-spectrin (SpC), DictyosteliumABP-120(ABP-120) (Noe-
gel et al ., 1989), human filamin (Hfil) (Gorlin et al ., 1990), and
chickfimbrin (Cfim) (de Arruda et al ., 1990) . Optimal alignment
was achieved using the computer program LINEUP (Devereux et
al ., 1984) . The a-actinin consensus sequence (AaC) was derived
from human placenta (Millake et al ., 1989), chick smooth muscle
(Baron et al ., 1987), chick skeletal muscle (Arimura et al ., 1988),
Drosophila (Fyrberg et al ., 1990), and Dictyostelium (Noegel et
al ., 1987) sequences. The dystrophin consensus sequence (DyC)
was derived from human (Koenig et al ., 1988) and chicken (Le-
maire et al ., 1988) sequences. The 0-spectrin consensus sequence
(SpC) was derived from human (Karinch et al ., 1990) andDroso-
phila (Byers et al ., 1989) sequences. Lowercase letters in the
a-actinin, dystrophin, and 0-spectrin consensus sequences repre-
sent positions where a consensus could not be derived, and the
residues found in thechickensmooth muscle a-actinin, humandys-
trophin, and human 0-spectrin sequences are shown at these posi-
tions . Theconsensus derived from all of these sequences (Con) is
shown, wherelowercase letters represent conserved residues, and
uppercase letters represent identical residues (boxed) . Dots repre-
sent positions where a consensus could not be derived . Residues
-8 to -1 in the AaC are unique to chicken skeletal muscle
a-actinin . The chicken fimbrin sequence starts at residue 69.
Obliques inserted into thefimbrinsequence represent points where
a number of nonhomologous residues have been omitted . The hu-
man 0-spectrin trypticpeptidecapable of actin-binding (Karinch et
al ., 1990) is indicated by asolid line . The27 residues shownto be
required for actin-binding in ABP-120 (Bresnick et al ., 1990) are
indicated by a dotted line . Solid arrowheads indicate the "KTFT"
residues which have been implicated in the dystrophin/actin inter-
action (Levine et al ., 1990). The extent of the deletion mutations
at theNH2- and COOH-terminal ends of thechickensmooth mus-
cle a-actinin actin-binding domain are shown. The thermolysin
protease cleavage site within chick skeletal muscle a-actinin is ar-
rowed (1). Numbering of residues is based on the chick smooth
muscle a-actinin sequence including the initiating methionine .
GST fusion protein
Protein present in
actin pellet
Wild-type a-actinin
actin-binding domain 92
KTFT deletion mutant 35
RSYS substitution mutant 52
EETFT substitution mutant 20
KAFT substitution mutant 48
KTAT substitution mutant 31
KTFA substitution mutant 25NH2-terminal residues 2-46, however, resulted in the ex-
pression of an insoluble protein. These residues are rela-
tively hydrophilic, the remainder ofthe actin-binding domain
beingpredominantly hydrophobic. Loss of these hydrophilic
residues may permit intermolecular hydrophobic interactions
which result in reduced solubility. Alternatively, deletion of
these residues might produce a marked change in conforma-
tion and therefore solubilityofthe protein, although a protein
lacking almost the entire actin-bindingdomain (pSVL/N222)
was soluble. Deletion of residues 217-242 and 196-242 at
the COOH terminus of the actin-binding domain was more
informative, and both mutants retained the ability to localize
to actin filaments and filament ends. From these results we
can conclude that the actin-binding site in a-actinin lies be-
tween residues 20 and 195. The conclusion that the extreme
NHZ-terminal region of a-actinin is not required for bind-
ing is consistent with the observation that the 27-kD polypep-
tide released from chick a-actinin by thermolysin is able to
bind to actin (Mimura and Asano, 1986) although it lacks
residues 1-24 (Davison et al ., 1989) . Furthermore, the ex-
treme NHZ-terminal region of this family of actin-binding
proteins shows no sequence relatedness (Fig. 9), making it
unlikely to be involved in binding to the highly conserved ac-
tin molecule.
Our initial attempts to further define the actin-binding site
in a-actinin using bacterially expressed proteins were en-
couraging. Thus a protein (residues 1-269) containing the
intact actin-binding domain remained soluble, and was able
to bind F-actin in vitro. The expressed actin-binding domain
deletion mutants accumulated in inclusion bodies from
which they could be solubilized using 6 M urea. However,
we were unable to identify conditions to maintain them in
solution after removal ofthe urea. We were able to overcome
this problem to some degree by expressing deletion mutants
as fusion proteins with GST. This approach has the added
advantage that the proteins can be purified by affinity chro-
matography using glutathione-agarose. The results of these
studies clearly demonstrate that NH2-terminal residues
1-107 and COON-terminal residues 190-242 are not re-
quired for actin binding. The actin-binding site in a-actinin
must therefore lie between residues 108 and 189.
It is interesting to compare these results with those gained
from studies on other members of this family of proteins. A
16.5-kD tryptic polypeptide derived from human/3-spectrin
has recently been demonstrated to bind F-actin (Karinch et
al., 1990) . The polypeptide spans residues 47-186 in the
(3-spectrin sequence which are equivalentto residues 25-158
in the chick smooth muscle a-actinin sequence (Fig. 9). In
addition, a 17-kD tryptic fragment derived from ABP-120
has also been reported to bind F-actin, whereas a 14-kD
fragment generated from this polypeptide was found to have
lost actin-binding activity (Bresnick et al., 1990). Protein se-
quence analysis showed that the NH2 termini of the 17- and
14-kD fragments were residues 89 and 115, respectively. The
authors conclude that the sequence between residues 89 and
115 is essential for actin binding. These 27 residues in ABP-
120 are equivalent to residues 108-134 in the chick smooth
muscle a-actinin sequence (Fig. 9). They are therefore con-
tained within the sequence in a-actinin (residues 108-189)
we have shown to be important in binding to actin. The se-
quence is also contained within the region in a-spectrin
thought to be important in actin binding (Karinch et al.,
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1990) . Furthermore, these 27 residues are highly conserved
in all members of this family of actin-binding proteins (Bres-
nick et al., 1990). The totally conserved residues within this
sequence are predominantly hydrophobic in nature. This
may indicate that binding of the a-actinin family of proteins
to actin involves predominantly hydrophobic interactions,
although it will be important to establish that these residues
are displayed on the surface of the protein.
Unfortunately, there appears to be no experimental evi-
dence concerning the nature ofthe interaction between actin
and members of this family of actin-binding proteins. It is
interesting to note that two possible a-actinin binding sites
have been identified on the surface of actin using chemical
crosslinking (Mimura and Asano, 1987). The first of these
sites is between actin residues 1 and 12, which are mainly
acidic in nature. The second site is between residues 86 and
123. Actin residues 90-103 have been shown to form a sur-
face loop (Kabsch et al., 1990) that is moderately hydro-
philic in nature (Collins and Elzinga, 1975) . Whether the
27 predominantly hydrophobic residues implicated in actin
binding from studies on ABP-120 (Bresnick et al., 1990) in-
teract with these regions of the actin molecule remains to be
established.
Evidence has been presented that the NHZ-terminal re-
gion of this family of actin-binding proteins arose by a gene
duplication event (de Arruda et al., 1990). Thus residues
18-140 ofchicksmooth muscle a-actinin can be aligned with
residues 141-245. Interestingly, the actin-binding domain of
chick skeletal muscle a-actinin can be cleaved almost ex-
actly in half by thermolysin (between aspartate 139 and
isoleucine 140 using the coordinates of the smooth muscle
isoform; see Fig. 9) (Davison, M. D., and D. R. Critchley,
unpublished data), supporting the view that the domain is
composed of two distinct segments. Whether the actin-
binding site is contained solely within the NH2-terminal
segment, as one might conclude from the studies on ABP-
120, or extends into the COOH-terminal segment remains to
be established.
Nuclear magnetic resonance experiments with a synthetic
peptide spanning residues 10-32 ofthe humandystrophin se-
quence suggest that it contains an actin-binding site (Levine
et al., 1990) . Further, the sequence KTFT whichis contained
within this peptide has been shown to interact with actin . The
sequence R/K KTFT is found in human, chick, and Dictyo-
stelium discoideum a-actinins, human and chickdystrophin,
human and Drosophila a-spectrin, and Dictyostelium ABP-
120, but the sequence is somewhat divergent in fimbrin and
filamin (Fig. 9) . We have attempted to clarify the importance
of this sequence in the interaction between a-actinin and
actin by mutagenesis. Deletion ofthis sequence (residues 36-
39 in the chicksmooth muscle protein) resulted in the expres-
sion of an apparently insoluble protein in Cos cells, but con-
servative and nonconservative substitutions did not affect the
ability of expressed a-actinin to target to actin filaments or
filament ends. In addition, when the actin-binding domains
of the KTFT mutants, including the deletion mutant, were
expressed as fusion proteins in E. coli, the proteins were still
able to bind F-actin. Wetherefore conclude that this sequence
is not essential to actin binding, although we do not exclude
the possibility that it contributes to the interaction. Indeed,
there was an apparent reduction in the ability of the KTFT
mutants to cosediment with actin, although we cannot rule
1378out the possibility that this was due to the instability of these
proteins. In common with a number of other actin-binding
proteins, a-actinin has been reported to bind to the acidic
NH2-terminal region of actin (Mimura and Asano, 1987).
The basic residues in the sequence R/K KTFT may be im-
portant in this respect.
Although the N112-terminal region of human dystrophin
shows a 45 % sequence identity to the actin-binding domain
of humana-actinin (67 % sequence similarity) (Fig. 9), there
is no direct evidence that dystrophin does in fact bind actin.
The experiments described in this study show for the first
time that the NH2-terminal region of dystrophin is indeed
functionally homologous to that of a-actinin . Thus, a chi-
meric protein in which the actin-binding domain of chick
a-actinin was replaced by residues 1-233ofhumandystrophin
localized to actin filaments and filamentends when expressed
in Cos cells. A bacterially expressed fusion protein contain-
ing dystrophin residues 1-233 also bound F-actin in vitro.
These results provide unequivocal evidence that dystrophin
is an F-actin binding protein .
The ability of the NH2-terminal region of dystrophin to
bind to actin is apparently at variance with the observed in-
tracellular distribution of the protein. Thus in skeletal mus-
cle, dystrophin is localized under the plasma membrane and
is not, for example, directly associated with the actin thin
filaments of the contractile apparatus (Bonilla et al., 1988 ;
Watkins et al., 1988). Furthermore, expression of the whole
dystrophin molecule in Cos cells leads to targeting of the ex-
pressed protein to the cell periphery, and not to the actin
stress fibers within the cell (Lee et al., 1991) . It would there-
fore seem likely that the dystrophin molecule contains addi-
tional sequences that are important in determining the intra-
cellular distribution of the protein. Dystrophin has been
shown to bind to a membrane glycoprotein found in the
skeletal muscle membrane (Ervasti et al ., 1990), and this
might be an important factor governing its location within
the cell. However, the region of the dystrophin molecule in-
volved in this interaction has yet to be defined. Interestingly,
a-actinin has also been reported to contain a binding site for
an integral membrane protein, and this site has been local-
ized to the four spectrin-like repeats contained within the
molecule (Otey et al., 1990). These repeats are homologous
to the 24 such repeats found in dystrophin (Davison and
Critchley, 1988; Koenig et al., 1988).
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